Abstract | BACKGROUND: OBJECTIVE: The aim of this report is to show the spectrum of presentations of patients with CAD and to outline the proper diagnostic workup of these individuals. METHODS: Phototesting was performed to determine the minimal erythema doses to ultraviolet (UV)A (315-400 nm) and UVB (280-315 nm) and photopatch testing and patch testing for each individual with the North American Contact Dermatitis Group Standard series and the Chemotechnique Plant series, supplemented by the Hausen Plant series and the patients' own products. RESULTS: CONCLUSION: CAD is persistent, with a classic presentation, and requires a specific diagnostic workup. Effective therapeutic options exist for patients with CAD.
|
Authors | Renée A Beach, Melanie D Pratt |
Journal | Journal of cutaneous medicine and surgery
(J Cutan Med Surg)
2009 May-Jun
Vol. 13
Issue 3
Pg. 121-8
ISSN: 1203-4754 [Print] United States |
PMID | 19426619
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
|
Topics |
- Chronic Disease
- Dermatitis, Atopic
(diagnosis)
- Diagnosis, Differential
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Patch Tests
(methods)
- Photosensitivity Disorders
(diagnosis, drug therapy)
- Skin
(radiation effects)
- Sunscreening Agents
(therapeutic use)
- Ultraviolet Rays
(adverse effects)
|